These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 12559678)

  • 1. Effect of AT1 receptor blockade on endothelial function in essential hypertension.
    Klingbeil AU; John S; Schneider MP; Jacobi J; Handrock R; Schmieder RE
    Am J Hypertens; 2003 Feb; 16(2):123-8. PubMed ID: 12559678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An angiotensin receptor blocker plus a diuretic is most effective in lowering blood pressure in the African American with hypertension on a supplemental salt diet.
    Basile JN
    J Clin Hypertens (Greenwich); 2001; 3(5):316-8. PubMed ID: 11675776
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-aged and older adults.
    Kaplon RE; Hill SD; Bispham NZ; Santos-Parker JR; Nowlan MJ; Snyder LL; Chonchol M; LaRocca TJ; McQueen MB; Seals DR
    Aging (Albany NY); 2016 Jun; 8(6):1167-83. PubMed ID: 27208415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Renin-Angiotensin-Aldosterone System Reactivity on Endothelial Function and Modulative Role of Valsartan in Male Subjects with Essential Hypertension.
    Jasiczek J; Trocha M; Derkacz A; Szahidewicz-Krupska E; Doroszko A
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA and mRNA analysis of angiotensin II-induced renal artery endothelial cell dysfunction.
    Liu Y; Jiang Y; Li W; Han C; Qi Z
    Exp Ther Med; 2020 Jun; 19(6):3723-3737. PubMed ID: 32346437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic Implications of eNOS Polymorphisms (
    Cozma A; Fodor A; Orasan OH; Vulturar R; Samplelean D; Negrean V; Muresan C; Suharoschi R; Sitar-Taut A
    In Vivo; 2019; 33(4):1051-1058. PubMed ID: 31280192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Vascular Function in Hypertensive Patients After Renin-Angiotensin System Blockad.
    Souza-Barbosa LA; Ferreira-Melo SLE; Ubaid-Girioli S; Nogueira EA; Yugar-Toledo JC; Moreno H
    J Clin Hypertens (Greenwich); 2006 Nov; 8(11):803-811. PubMed ID: 29024440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.
    Alhusban A; Kozak A; Pillai B; Ahmed H; Sayed MA; Johnson MH; Ishrat T; Ergul A; Fagan SC
    PLoS One; 2017; 12(6):e0178867. PubMed ID: 28640888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.
    Giles TD; Cockcroft JR; Pitt B; Jakate A; Wright HM
    J Hypertens; 2017 Sep; 35(9):1758-1767. PubMed ID: 28509722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong).
    Park JS; Shin JH; Hong TJ; Seo HS; Shim WJ; Baek SH; Jeong JO; Ahn Y; Kang WC; Kim YH; Kim SH; Hyon MS; Choi DH; Nam CW; Park TH; Lee SC; Kim HS
    Drug Des Devel Ther; 2016; 10():2599-609. PubMed ID: 27574399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial.
    van Poppel PC; Breedveld P; Abbink EJ; Roelofs H; van Heerde W; Smits P; Lin W; Tan AH; Russel FG; Donders R; Tack CJ; Rongen GA
    PLoS One; 2015; 10(7):e0128695. PubMed ID: 26192328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aliskiren on arterial stiffness and endothelial function in patients with primary hypertension.
    Bonadei I; Vizzardi E; D'Aloia A; Sciatti E; Raddino R; Metra M
    J Clin Hypertens (Greenwich); 2014 Mar; 16(3):202-6. PubMed ID: 24708382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid artery intima-media thickness and the renin-angiotensin system.
    Johnson CT; Brewster LP
    Hosp Pract (1995); 2013 Apr; 41(2):54-61. PubMed ID: 23680737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of calcium channel blockers.
    Preston Mason R
    Curr Hypertens Rep; 2012 Aug; 14(4):293-303. PubMed ID: 22610475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants.
    Mason RP; Jacob RF; Kubant R; Jacoby A; Louka F; Corbalan JJ; Malinski T
    Br J Clin Pharmacol; 2012 Jul; 74(1):141-6. PubMed ID: 22283728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of valsartan in obese and non-obese pediatric hypertensive patients.
    Meyers KE; Lieberman K; Solar-Yohay S; Han G; Shi V
    J Clin Hypertens (Greenwich); 2011 Oct; 13(10):758-66. PubMed ID: 21974764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthases: regulation and function.
    Förstermann U; Sessa WC
    Eur Heart J; 2012 Apr; 33(7):829-37, 837a-837d. PubMed ID: 21890489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Förstermann U; Li H
    Br J Pharmacol; 2011 Sep; 164(2):213-23. PubMed ID: 21198553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension management and microvascular insulin resistance in diabetes.
    Ko SH; Cao W; Liu Z
    Curr Hypertens Rep; 2010 Aug; 12(4):243-51. PubMed ID: 20582734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation.
    Yilmaz MI; Carrero JJ; Martín-Ventura JL; Sonmez A; Saglam M; Celik T; Yaman H; Yenicesu M; Eyileten T; Moreno JA; Egido J; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1174-81. PubMed ID: 20430947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.